8
Total investments
2
Early stage
2
Mid stage
2
Late stage
8y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jul 2024
Streetbees pioneered conversational research, leveraging AI to decode complex human behaviour over the last decade. By combining this deep expertise with the latest Large Language Models, we’ve now made it un-bee-lievably easy for you to get the bespoke insights you need to fuel your decisions with our agile insights platform, SBX.
No more painful processes. No more unanswered questions. No more compromises.
Since 2015, Streetbees has raised over $50 million in investment and has grown from 0 to 200 employees. The company was voted one of LinkedIn’s Top 15 UK Startups 2020 and 2021, was awarded ‘AI Product of the year’ by Computing Magazine in 2021 and won the MRS Best Innovation in Data Analytics Award in 2022. In 2024, we have been nominated as finalists for MRS Best data Solution, National Technology and Digital Transformation Awards.
www.streetbees.com
Investor
Mar 2023
Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. This approach offers patients a simpler, safer, and more accessible alternative to today’s complex treatments. Built from day one with a fully integrated platform spanning circular and linear RNA, targeted delivery, and AI-guided design, Orbital is working to develop durable, programmable therapies tailored to the distinct biology of each disease. The company’s lead program, OTX-201, targets autoimmune disease through B cell depletion to reset the immune system. Orbital’s platform is built for expansion into broader autoimmune indications, oncology, next-generation vaccines, and protein therapeutics. Led by a team with deep expertise in RNA science, clinical development, and commercialization, Orbital is united by a shared commitment to reach more patients, in more places, with fewer barriers. Learn more at www.orbitaltx.com.
Board Observer
Jan 2022
Aliro, The Quantum Networking Company®, offers AliroNet® to run entanglement-based Quantum Networks for applications such as Quantum Secure Communications (QSC), secure access to clouds and data centers, networking of quantum computers, and networking of distributed quantum sensors. AliroNet is also used to implement comprehensive Advanced Secure Networks which include Post-Quantum Cryptography (PQC). Aliro provides quantum network simulation as a professional service or as an on-premises offer. AliroNet® users include utility companies, telecommunications providers, public sector organizations, enterprises, and researchers who are simulating, designing, piloting, orchestrating, and building the worlds first quantum networks. Visit us at AliroTech.com.
Investor
Aug 2021
Five Sigma offers AI and automation technology for claims handling. Clive™, the industry’s first Multi-Agent AI Claims Expert, working on top of any existing claims management system (CMS), and Five Sigmas AI-native Claims Management Platform.
For P&C carriers, MGAs, TPAs, and reinsurers, Five Sigma delivers tangible results through claims technology: cost savings, productivity boost, cycle time reduction, improved accuracy, and better policyholder service.
Clive™, our award-winning Multi-Agent AI Claims Expert, adds AI and automation to any existing system to automate routine tasks, dynamically plan claim handling, and advance the claim automatically according to the insurer’s operating procedure (SOP). Clive manages multiple AI agents that handle and automate different tasks and claim handling stages, including: intake, triage, liability assessment, coverage, communications, fraud detection, compliance, settlement, and more.
Our customers can deploy Clive AI quickly, one agent at a time, and expand as they go. Adjusters are freed to focus on complex decision-making and better customer service.
Five Sigma’s Claims Management Platform is an AI-native CMS, with Clive built-in. Our platform includes 360° claim visibility, an omnichannel communication hub, and easily configurable workflows — offering unmatched efficiency and cost savings.
Investor
Mar 2021
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
Board Observer
Jan 2021
Matterworks is using the power of AI to fundamentally change the impact of biological measurements and observations.
Board Observer
Jan 2021
BigObject Inc. provides lightning-fast Big Data Analytics with patented In-Data Computing technology. We focus on Big Data Analytics performance improvement and constructing live-DMP (Data Management Platform) Infrastructure for our customers.
Our recent new product release of STAI (Spatial-Temporal AI) in SVRA (Smart Video Reasoning Analytics) provides customers the ability to increase the efficiency and effectiveness in dealing with video complex event detection.
Board Member
Sep 2018
hoolah is Asias leading omni-channel buy now pay later platform.
We help merchants in Asia to solve the critical challenges of generating new customers, getting them to return, conversion and basket size by driving consumer affordability - responsibly.
Consumers can enrich their lifestyles - whatever that means to them and worry less about price to buy the things they want or need by paying over a short duration aligned to their budgeting and salary cycles. There is no interest charged ever and no hidden costs.
hoolah. Creating mutual value through responsible affordability
Experience · 10 entries
All (10)
Investments (8)
Founder (1)
Board (5)
2024
Board Observer
Jul 2024
Streetbees pioneered conversational research, leveraging AI to decode complex human behaviour over the last decade. By combining this deep expertise with the latest Large Language Models, we’ve now made it un-bee-lievably easy for you to get the bespoke insights you need to fuel your decisions with our agile insights platform, SBX.
No more painful processes. No more unanswered questions. No more compromises.
Since 2015, Streetbees has raised over $50 million in investment and has grown from 0 to 200 employees. The company was voted one of LinkedIn’s Top 15 UK Startups 2020 and 2021, was awarded ‘AI Product of the year’ by Computing Magazine in 2021 and won the MRS Best Innovation in Data Analytics Award in 2022. In 2024, we have been nominated as finalists for MRS Best data Solution, National Technology and Digital Transformation Awards.
www.streetbees.com
2023
Investor
Mar 2023
Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. This approach offers patients a simpler, safer, and more accessible alternative to today’s complex treatments. Built from day one with a fully integrated platform spanning circular and linear RNA, targeted delivery, and AI-guided design, Orbital is working to develop durable, programmable therapies tailored to the distinct biology of each disease. The company’s lead program, OTX-201, targets autoimmune disease through B cell depletion to reset the immune system. Orbital’s platform is built for expansion into broader autoimmune indications, oncology, next-generation vaccines, and protein therapeutics. Led by a team with deep expertise in RNA science, clinical development, and commercialization, Orbital is united by a shared commitment to reach more patients, in more places, with fewer barriers. Learn more at www.orbitaltx.com.
2022
Board Observer
Jan 2022
Aliro, The Quantum Networking Company®, offers AliroNet® to run entanglement-based Quantum Networks for applications such as Quantum Secure Communications (QSC), secure access to clouds and data centers, networking of quantum computers, and networking of distributed quantum sensors. AliroNet is also used to implement comprehensive Advanced Secure Networks which include Post-Quantum Cryptography (PQC). Aliro provides quantum network simulation as a professional service or as an on-premises offer. AliroNet® users include utility companies, telecommunications providers, public sector organizations, enterprises, and researchers who are simulating, designing, piloting, orchestrating, and building the worlds first quantum networks. Visit us at AliroTech.com.
2021
Investor
Aug 2021
Five Sigma offers AI and automation technology for claims handling. Clive™, the industry’s first Multi-Agent AI Claims Expert, working on top of any existing claims management system (CMS), and Five Sigmas AI-native Claims Management Platform.
For P&C carriers, MGAs, TPAs, and reinsurers, Five Sigma delivers tangible results through claims technology: cost savings, productivity boost, cycle time reduction, improved accuracy, and better policyholder service.
Clive™, our award-winning Multi-Agent AI Claims Expert, adds AI and automation to any existing system to automate routine tasks, dynamically plan claim handling, and advance the claim automatically according to the insurer’s operating procedure (SOP). Clive manages multiple AI agents that handle and automate different tasks and claim handling stages, including: intake, triage, liability assessment, coverage, communications, fraud detection, compliance, settlement, and more.
Our customers can deploy Clive AI quickly, one agent at a time, and expand as they go. Adjusters are freed to focus on complex decision-making and better customer service.
Five Sigma’s Claims Management Platform is an AI-native CMS, with Clive built-in. Our platform includes 360° claim visibility, an omnichannel communication hub, and easily configurable workflows — offering unmatched efficiency and cost savings.
Investor
Mar 2021
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
Show all 10 entries ↓
Investment activity
2018–2024 · 8 investments
Recent (last 2 years)Earlier
